Skip to main content
. 2020 Nov 30;14(11):e0008873. doi: 10.1371/journal.pntd.0008873

Fig 4. Immunoreactivity of the commercial B. multicinctus antivenin and the prepared antiserum against top Chinese dangerous terrestrial snake venoms.

Fig 4

SDS-PAGE of nine used snake venoms under non-reducing conditions, 25 μg/sample (A). Western blot revealed by B. multicinctus antivenin under non-reducing conditions (B). Western blot revealed by B. multicinctus antivenin under reducing conditions (C). Western blot revealed by normal horse IgG under non-reducing conditions (D). Western blot revealed by prepared anti-α-BGT antiserum under non-reducing conditions (E). Western blot revealed by prepared anti-β-BGT antiserum under non-reducing conditions (F). Western blot revealed by prepared anti-γ-BGT antiserum under non-reducing conditions (G). Western blot revealed by normal rabbit IgG under non-reducing conditions (H). Bm: B. multicinctus; Bf: B. fasciatus; Na: N. atra; Oh: O. hannah; Da: D. acutus; Ts: T. stejnegeri; Dr: Daboia russelii siamensis; Pm: P. mucrosquamatus; Gb: G. brevicaudus. 10 μg/sample was loaded for Western blot experiments.